[PDF] Top 20 Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema
Has 10000 "Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema" found on our website. Below are the top 20 most common "Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema".
Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema
... study, intravitreal injection of pegaptanib did not significantly alter the size of the FAZ in participants with varying degrees of ischemia and ...with ischemic DME with pegaptanib, despite ... See full document
7
An open-label, one-year, noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema
... of treatment as evaluated by change in BCVA from baseline to end of treat- ...Early Treatment Diabetic Retinopathy Study charts starting at 4 ...each treatment visit, and at ... See full document
7
<p>Dexamethasone implant in the management of diabetic macular edema from clinician’s perspective</p>
... following intravitreal injection of DEX ...to macular edema of various origin, there was a small percen- tage of patients in whom the IOP increase already occurred at 8 days and 1 ... See full document
12
Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema
... On comparing the results of the outcome measures for each pair of drugs, we found that there was a significant dif- ference in the maintained improvement in visual acuity and the decrease in the CMT at week 12 on using ... See full document
6
<p>Fluocinolone acetonide 0.19 mg intravitreal implant improves foveal thickness and reduces treatment burden for up to 1 year in eyes with persistent diabetic macular edema</p>
... non-biodegradable, intravitreal implant (Iluvien®; Alimera Sciences, ...the treatment of DME in eyes previously treated with a course of corticoster- oids without a clinically signi fi cant rise in ... See full document
9
Remote Ischemic Preconditioning and Diabetic Macular Edema
... central macular thickness in case ...central macular thickness ( P - value: ...anti-VEGF treatment. Keywords: Ischemic preconditioning, Type 2 diabetes mellitus, Macular edema, ... See full document
6
Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema
... that treatment with ranibizumab both as monotherapy or combined treatment were significantly better than laser monotherapy in terms of VA functionally and OCT findings ...Repeated intravitreal ... See full document
17
Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema
... of macular edema with loss of visual acuity whereas six months after SBT injection retinal thickness and visual acuity remained ...follow-up. Macular edema is the main cause of loss of visual ... See full document
7
Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates
... of intravitreal bevacizumab for DME with subfoveal and perifoveal hard exudates in terms of visual ...combined treatment modalities for this pattern of ... See full document
8
Primary treatment of diabetic macular edema
... of macular edema, attention has recently focused on intravitreal injections of anti-VEGF ...by intravitreal injection bind to VEGF and thereby decrease downstream effects on vascular ... See full document
8
Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema
... after treatment by measuring the BCVA 1 day after IVR ...central macular thick- ness 1 month after IVB injection in patients with both DME and macular oedema after branch retinal vein occlusion ... See full document
6
Critical appraisal of ranibizumab in the treatment of diabetic macular edema
... Abstract: Diabetic retinopathy is the leading cause of blindness among individuals of working age in industrialized nations, with most of the vision loss resulting from diabetic macular edema ... See full document
11
Population pharmacokinetics of pegaptanib sodium (Macugen<sup>®</sup>) in patients with diabetic macular edema
... trial, intravitreal pegaptanib ...with diabetic macular edema every 6 weeks for 12–30 ...the pegaptanib plasma concentration–time ...clearance. Pegaptanib clearance was ... See full document
13
Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
... more intravitreal DEX implants and followed up for at least 6 months and a BCVA ≥30 and ≤ 80 letters [Early Treatment Diabetic Retinopathy Study (ETDRS) ...mellitus, macular ischemia, a ... See full document
8
Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients
... anti-inflammatory treatment is to not only treat but also prevent the development of ...that intravitreal TA (IVTA) is efficacious in the treatment of refractory ... See full document
9
The effects and safety of intravitreal triamcinolone injections in the treatment of diabetic macular edema
... Two different pharmaceutical triamcinolone acetonide products were used, depending on availability: preserva- tive-free Aurocort (Aurolab, Veerapanjan, India), intend- ed for intravitreal use; or Kenalog ... See full document
5
The efficacy and safety of aflibercept and conbercept in diabetic macular edema
... Abstract: Diabetic macular edema (DME) has shown an increasing prevalence during the past years and is the leading cause of diabetic retinopathy ...Traditional treatment modalities ... See full document
13
Intravitreal gas injection for the treatment of diabetic macular edema
... and edema in these refractory cases was ...on macular edema by a number of mechanisms: reduced VEGF production caus- ing decreased retinal vascular permeability; autoregulatory arteriolar ... See full document
6
Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema
... Abstract: Diabetic macular edema (DME) remains one of the leading causes of moderate to severe vision loss. Although laser photocoagulation was the standard of care for several years, few patients ... See full document
10
Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
... 42 diabetic patients were included in this prospective randomized ...with intravitreal aflibercept injection and patients in group II (35 eyes) were treated with intravitreal ranibizumab ... See full document
5
Related subjects